Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Yasuo, Hirayama"'
Autor:
Hiroto Horiguchi, Kohichi Takada, Yusuke Kamihara, Soushi Ibata, Satoshi Iyama, Tsutomu Sato, Tsuyoshi Hayashi, Koji Miyanishi, Yasushi Sato, Rishu Takimoto, Masayoshi Kobune, Ko Kobayashi, Yasuo Hirayama, Naoya Masumori, Tadashi Hasegawa, Junji Kato
Publikováno v:
Case Reports in Oncology, Vol 7, Iss 2, Pp 565-570 (2014)
Radiation therapy (RTx) has been employed as a curative therapy for prostatic adenocarcinoma. RTx-induced sarcomas (RISs) are rare, late adverse events, representing less than 0.2% of all irradiated patients. RISs are more aggressive tumors than pros
Externí odkaz:
https://doaj.org/article/49752c21170b44138787e3c0e5a43ee4
Publikováno v:
JOURNAL OF CHEMICAL ENGINEERING OF JAPAN. 54:117-125
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::935e8e85c5b64132d87cc8843ac44532
https://doi.org/10.1252/jcej.20we156
https://doi.org/10.1252/jcej.20we156
Autor:
Terufumi Kubo, Yasuo Hirayama, Shugo Sakihama, Tomoki Kikuchi, Yoshihiko Hirohashi, Mitsuhiro Tsujiwaki, Kennosuke Karube, Tadashi Hasegawa, Toshihiko Torigoe
Publikováno v:
Pathology, research and practice. 234
Carriers of oncogenic human T-cell leukemia virus type 1 (HTLV-1) can develop adult T-cell leukemia/lymphoma (ATLL). While an increasing number of animal models of HTLV-1 infection have revealed that malignant tumors with a histiocytic phenotype can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb4d3dbd086792c868b6c2db0ec381e6
https://pubmed.ncbi.nlm.nih.gov/35525174
https://pubmed.ncbi.nlm.nih.gov/35525174
Autor:
Makoto, Meguro, Tetsufumi, Someya, Tousei, Ohmura, Kiyoteru, Kashiwagi, Yoko, Kuga, Takayuki, Machino, Toshiro, Kusakabe, Yasuo, Hirayama, Nobuo, Kondo
Publikováno v:
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology. 117(4)
We report the case of a 61-year-old woman with a collision cancer of primary squamous cell carcinoma (SCC) and adenocarcinoma in the stomach that was cured surgically. She achieved complete remission after treatment (R-CHOP and radiation therapy;40.8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e5f30af39683a0362ed5c8bc8d8f9dc1
https://pubmed.ncbi.nlm.nih.gov/32281575
https://pubmed.ncbi.nlm.nih.gov/32281575
Publikováno v:
Japanese journal of clinical oncology. 50(8)
Objective We conducted a questionnaire survey of oncology specialists to investigate the frequency of administration of different drugs for the management of chemotherapy-induced peripheral neuropathy in Japan in 2015. Our group published Clinical Gu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f9f8774e700c47327d5f231d4475163
https://pubmed.ncbi.nlm.nih.gov/32424420
https://pubmed.ncbi.nlm.nih.gov/32424420
Autor:
Akio Mori, Takeo Sarashina, Hajime Sakai, Satoshi Yamamoto, Masaki Yamamoto, Kyuhei Kohda, Ryoji Kobayashi, Mitsutoshi Kurosawa, Yasuo Hirayama, Kazuya Sato, Tohru Takahashi, Yoshihito Haseyama, Hajime Kobayashi, Takashi Fukuhara, Motohiro Shindo, Yasutaka Kakinoki, Shuichi Ota, Masahiro Imamura, Toshihiro Matsukawa, Mitsufumi Nishio, Takeshi Kondo, Hiroshi Ikeda, Hiroyuki Kuroda, Shinichi Ito, Toshimichi Ishihara, Makoto Yoshida
Publikováno v:
European Journal of Haematology. 101:95-105
OBJECTIVE This multicenter cooperative study aimed to analyze the adverse events (AEs) associated with tyrosine kinase inhibitors (TKIs) used as initial treatment for chronic-phase chronic myeloid leukemia (CML-CP) and their impact on outcome. METHOD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2153135e9eed20c620bc3cef2ed2af11
https://doi.org/10.1111/ejh.13081
https://doi.org/10.1111/ejh.13081
Autor:
Kazuaki Asaishi, Hiroyuki Kawasaki, Goro Kutomi, Ichiro Takemasa, Tousei Ohmura, Tetsuhumi Someya, Hidekazu Kameshima, Yasuo Hirayama, Kunihiko Ishitani
Publikováno v:
Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons). 42:743-751
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd2a897b41393a0ee3dced184e3d1d99
https://doi.org/10.4030/jjcs.42.743
https://doi.org/10.4030/jjcs.42.743
Autor:
Masayoshi Kobune, Kohichi Takada, Kazuyuki Murase, Kunihiko Ishitani, Tsutomu Sato, Yusuke Kamihara, Takeshi Terui, Junji Kato, Satoshi Iyama, Yasuo Hirayama
Publikováno v:
Journal of Hematology And Oncology Research. 2:22-28
Objective Hospital construction work, among other environmental factors, is a risk factor for invasive aspergillosis (IA). Methods We retrospectively surveyed the incidence of IA in hematology-oncology patients before and during hospital construction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::460542290076b6a7aee965372590f3b1
https://doi.org/10.14302/issn.2372-6601.jhor-15-799
https://doi.org/10.14302/issn.2372-6601.jhor-15-799
Autor:
Noriyuki Sato, Haruyuki Ito, Yasuo Hirayama, Takeshi Terui, Toshihiko Kusakabe, Satoko Ito, Kunihiko Ishitani
Publikováno v:
International journal of clinical oncology. 24(5)
The purpose of this study was to detect background factors that might be associated with the therapeutic and curative outcome of chemotherapy in elderly cancer patients aged over 75 years. A retrospective study was conducted for elderly cancer patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b1379ba13574304dbfe46abda29cca5
https://pubmed.ncbi.nlm.nih.gov/30607523
https://pubmed.ncbi.nlm.nih.gov/30607523
Autor:
Naoya Masumori, Ko Kobayashi, Tadashi Hasegawa, Hiroto Horiguchi, Soushi Ibata, Tsuyoshi Hayashi, Tsutomu Sato, Koji Miyanishi, Junji Kato, Yasuo Hirayama, Rishu Takimoto, Satoshi Iyama, Yasushi Sato, Kohichi Takada, Masayoshi Kobune, Yusuke Kamihara
Publikováno v:
Case Reports in Oncology, Vol 7, Iss 2, Pp 565-570 (2014)
Case Reports in Oncology
Case Reports in Oncology
Radiation therapy (RTx) has been employed as a curative therapy for prostatic adenocarcinoma. RTx-induced sarcomas (RISs) are rare, late adverse events, representing less than 0.2% of all irradiated patients. RISs are more aggressive tumors than pros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93d3f79bd953a44ccea50759f07ace8f
http://www.karger.com/Article/FullText/366294
http://www.karger.com/Article/FullText/366294